Skip to content

Study on synergistic enhancement rehabilitation technology of nerve regulation and limb movement

Study on synergistic enhancement rehabilitation technology of nerve regulation and limb movement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057240
Enrollment
Unknown
Registered
2022-03-04
Start date
2022-02-21
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Cerebellum-M1 group:transcranial magnetic stimulation (TMS)
Cerebellum-SMA group:transcranial magnetic stimulation (TMS)
Cerebellum-cerebellum group:transcranial magnetic stimulation (TMS)

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-75 years; 2. The first occurrence of unilateral hemispheric subcortical stroke, the course of disease >= 1 month; 3. The diagnosis met the criteria of "Key Points for the Diagnosis of Various Cerebrovascular Diseases in China" in 2019; 4. Motor dysfunction; 5. The condition is stable, conscious, and vital signs are stable; 6. Willing to cooperate with examination, intervention and follow-up; 7. The informed consent is signed by the patient himself or by his legal representative or guardian.

Exclusion criteria

Exclusion criteria: 1. Patients with serious primary diseases of heart, liver, kidney and hematopoietic system; 2. Patients with limb motor dysfunction caused by other non-cerebrovascular pathogens (such as peripheral nerve injury, spinal cord injury, fracture, congenital joint deformity, etc.); 3. Patients with a history of mental disorders or drug abuse; 4. Patients with previous history of epilepsy, metal implants in the brain that cannot be removed, skull defects and other contraindications of TMS; 5. May cause unpredictable influence on the research results; 6. Pregnant and lactating women; 7. Those who are not expected to complete the trial and have poor compliance.

Design outcomes

Primary

MeasureTime frame
Berg Balance Scale;Fugl-meyer assessment of motor function;

Secondary

MeasureTime frame
Action Research Arm Test, ARAT;Modified Barthel Index;functional comprehensive assessment;Functional Near Infrared Spectrum Instrument;

Countries

China

Contacts

Public ContactHu Ruiping

Department of Rehabilitation Medicine, Huashan Hospital Affiliated to Fudan University

rphu79@163.com+86 15102161500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026